Smartphone-Delivered Treatment for Suicidal Ideation

AC
Overseen ByAdam C Jaroszewski, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a smartphone treatment called Therapeutic Evaluative Conditioning for Suicide (TEC-S) to help reduce suicidal thoughts and behaviors. Researchers aim to determine if this app-based approach is safe, acceptable, and effective for individuals with frequent and recent suicidal thoughts. Participants will use either an active version of the app or a similar inactive version for comparison. This trial suits adults in the Boston area who have recently experienced suicidal thoughts and have access to a smartphone and Wi-Fi. As an unphased trial, it offers the opportunity to contribute to innovative research that could shape future treatments for suicidal thoughts.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this smartphone-delivered intervention is safe for reducing suicidal thoughts and behaviors?

Research has shown that Therapeutic Evaluative Conditioning for Suicide (TEC-S), a smartphone-delivered treatment, is generally safe for users. Studies have found that TEC-S can significantly reduce self-harming behaviors and suicidal thoughts without causing serious side effects. For instance, one study reported a 32% to 40% reduction in self-cutting and a 21% to 77% decrease in suicide planning over a month. These findings suggest that TEC-S is well-tolerated, with no major negative effects reported, making it a promising option for safely managing suicidal thoughts.12345

Why are researchers excited about this trial?

Most treatments for suicidal ideation involve therapy sessions and medications that aim to stabilize mood and reduce depressive symptoms. However, the Therapeutic Evaluative Conditioning for Suicide (TEC-S) is unique because it leverages smartphone technology to deliver its intervention. This method offers the potential for immediate accessibility and convenience, allowing individuals to engage with the treatment anytime and anywhere. Researchers are excited about this approach because it could provide a scalable and cost-effective solution that reaches people who might not have access to traditional therapy. Additionally, by using evaluative conditioning techniques, TEC-S aims to address the underlying cognitive patterns associated with suicidal thoughts, which could offer a novel mechanism of action compared to existing treatments.

What evidence suggests that this smartphone-delivered treatment could be effective for reducing suicidal thoughts and behaviors?

Research shows that the smartphone app, Therapeutic Evaluative Conditioning for Suicide (TEC-S), has promising results. In earlier studies, the app reduced self-harm by 32% to 40% and lowered plans for suicide by 21% to 77% over a month. However, these studies did not find a significant impact on directly reducing suicidal thoughts. Additionally, the positive effects did not persist one month after the treatment ended. In this trial, participants will receive either the active TEC-S or an inactive version as a placebo comparator. While these early results are encouraging, they suggest that TEC-S might be more effective at reducing certain behaviors rather than suicidal thoughts.12456

Who Is on the Research Team?

AC

Adam C Jaroszewski, PhD

Principal Investigator

Harvard Medical School, Massachusetts General Hospital

Are You a Good Fit for This Trial?

This trial is for adults (18+) living near Boston who have had frequent suicidal thoughts in the past month, own a smartphone, can access Wi-Fi at least sometimes, speak English, and are willing to provide an emergency contact.

Inclusion Criteria

I am 18 years old or older.
I can provide an emergency contact.
I have had frequent suicidal thoughts in the last month.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either inactive TEC or active TEC-S intervention delivered via smartphone for 30 days, with 3x daily ecological momentary assessments

4 weeks
Daily assessments (remote)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Therapeutic Evaluative Conditioning for Suicide (TEC-S)

Trial Overview

The study compares a new smartphone-based therapy called TEC-S designed to reduce suicidal thoughts with an inactive version of the same app. Participants are randomly assigned to one group or the other.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Smartphone-delivered active Therapeutic Evaluative Conditioning for Suicide (active TEC)Experimental Treatment1 Intervention
Group II: Smartphone-delivered inactive Therapeutic Evaluative Conditioning (inactive TEC)Placebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Citations

A Randomized Controlled Trial of a Smartphone Delivered ...

This study aims to evaluate the acceptability, safety, and efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for ...

Mobile Health Technology Interventions for Suicide Prevention

This review aimed to examine the effectiveness of currently available mobile health (mHealth) technology tools in reducing suicide-specific outcomes.

Therapeutic Evaluative Conditioning for Suicidal Thoughts ...

Delivered through a smartphone app, TEC reduced self-cutting by 32% to 40% and plans for suicide by 21% to 77% over a month.

TEC-TEC: An app for evaluative conditioning

However, there were no effects on suicide ideation, treatment gains were not maintained at the one-month post-treatment follow-up, and several study design ...

Examining the efficacy of a digital therapeutic to prevent ...

The central focus of this study is to test the efficacy of Aviva, a scalable, digital adaptation of Brief Cognitive Behavioral Therapy for Suicide Prevention in ...

Study Details | NCT06967545 | A One-Arm Open Trial of a ...

This study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative ...